sub:assertion {
  <http://purl.obolibrary.org/obo/DOID_6419> bl:category bl:Disease .
  sub:association rdf:object <http://purl.obolibrary.org/obo/DOID_6419> ;
    rdf:predicate bl:treats ;
    rdf:subject <https://identifiers.org/drugbank:DB00770> ;
    a rdf:Statement ;
    rdfs:label "prostin vr pediatric sterile solution is indicated for palliative not definitive therapy to temporarily maintain the patency of the ductus arteriosus until corrective or palliative surgery can be performed in neonates who have congenital heart defects and who depend upon the patent ductus for survival such congenital heart defects include pulmonary atresia pulmonary stenosis tricuspid atresia tetralogy of fallot interruption of the aortic arch coarctation of the aorta or transposition of the great vessels with or without other defects in infants with restricted pulmonary blood flow the increase in blood oxygenation is inversely proportional to pretreatment po 2 2 2 prostin vr pediatric should be administered only by trained personnel in facilities that provide pediatric intensive care" ;
    bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation ;
    bl:provided_by <https://w3id.org/um/NeuroDKG> ;
    bl:relation nkg:SymptomaticReliefIndication .
  <https://identifiers.org/drugbank:DB00770> bl:category bl:Drug .
}